TipRanks
Advertisement
Advertisement
Tandem Diabetes Care: Buy Rating Reaffirmed on Transformation Momentum and Innovation Catalysts; $40 Price Target Maintained
PremiumRatingsTandem Diabetes Care: Buy Rating Reaffirmed on Transformation Momentum and Innovation Catalysts; $40 Price Target Maintained
2M ago
Tandem Diabetes Care Earnings Call Highlights Growth
Premium
Company Announcements
Tandem Diabetes Care Earnings Call Highlights Growth
2M ago
Tandem Diabetes price target lowered to $26 from $30 at RBC Capital
Premium
The Fly
Tandem Diabetes price target lowered to $26 from $30 at RBC Capital
2M ago
Tandem Diabetes sees FY26 revenue $1.065B-$1.085B, consensus $1.08B
PremiumThe FlyTandem Diabetes sees FY26 revenue $1.065B-$1.085B, consensus $1.08B
2M ago
TNDM Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
TNDM Earnings this Week: How Will it Perform?
2M ago
Intuit downgrade, Intuitive Surgical upgraded: Wall Street’s top analyst calls
Premium
The Fly
Intuit downgrade, Intuitive Surgical upgraded: Wall Street’s top analyst calls
2M ago
Tandem Diabetes resumed with a Neutral at UBS
PremiumThe FlyTandem Diabetes resumed with a Neutral at UBS
2M ago

Trending

Name
Price
Price Change
S&P 500
―
Dow Jones
―
Nasdaq 100
―